Litigation Against Illumina, Life Technologies Continues

WALTHAM, Mass., May 17, 2012 (BUSINESS WIRE) -- Affinnova, Inc., the global leader in innovation software and services, has announced record sales for the prior twelve months ending March, 2012. Total sales increased 43% compared to the previous 12-month period. Non-U.S. sales rose to 18% of the business overall, as Affinnova has aggressively expanded its operations in Europe, hiring staff in the United Kingdom, France and Germany.

WALTHAM, Mass., May 14, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Mayo Medical Laboratory (Mayo) now offers galectin-3 testing services to its laboratory customers and physicians. Mayo will offer the BGM Galectin-3^TM test, which was cleared by the U.S.

WALTHAM, Mass., May 14, 2012 (GlobeNewswire via COMTEX) -- BG Medicine, Inc.

Company to Advance its lead Drug Candidate, EBI-005, into Clinic Development for Dry Eye Disease

By Karen Weintraub Cambridge, Massachusetts

The new antismoking technique uses nanoparticles to trigger an immune response.

By Conor Myhrvold

BILLERICA, Mass., April 25, 2012 -- /PRNewswire/ -- Seahorse Bioscience, the leader in cellular bioenergetic measurements, announced the launch of its newest stress test kit at the American Association of Cancer Research (AACR) Annual Meeting 2012. The XF Glycolysis Stress Test Kit is the first Standard for measuring glycolytic capacity in cells.

 Click here to see announcement.